What is iCleanse?
iCleanse specializes in providing Swift UV units, a dual-purpose solution designed to enhance hygiene and generate advertising revenue for businesses. These units are engineered to disinfect high-touch surfaces, including mobile phones, tablets, and body cameras, with a notable application in over 100 U.S. hospitals. The Swift UV disinfection stations offer rapid, 15-second phone disinfection while simultaneously displaying digital content on integrated 10-inch LCD screens. This allows businesses to engage audiences with educational material, branding, or advertising, creating a unique value proposition in public and commercial spaces.
How much funding has iCleanse raised?
iCleanse has raised a total of $2.5M across 2 funding rounds:
Debt
$1.5M
Debt
$1M
Debt (2022): $1.5M with participation from Enhanced Capital
Debt (2023): $1M led by Enhanced Capital
Key Investors in iCleanse
Enhanced Capital
Enhanced Capital is a national asset management firm focused on providing investment capital to underserved small businesses. They specialize in strategies like project finance and sustainable infrastructure, aiming to unlock private sector resources for economic development and job creation.
What's next for iCleanse?
The substantial enterprise-level funding and recent strategic investment position iCleanse for accelerated expansion and product development. This capital infusion is expected to fuel the scaling of its operations, enhance its advertising platform capabilities, and broaden its market reach, particularly within healthcare and other high-traffic environments. The company's focus on combining essential hygiene solutions with a robust digital advertising revenue stream suggests a strategic move towards becoming a dominant player in the smart disinfection and digital out-of-home advertising sectors.
See full iCleanse company page
